Generate QR code
Open Access
Subscription Access
Genetic variants associated with hemostatic disorders in patients seeking medical care in a multidisciplinary medical hospital
https://doi.org/10.25557/2073-7998.2025.09.114-116
Abstract
The paper presents the results of a study of genetic variants F2 G20210A, F5 G1691A, F7 G10976A, F13A G103T, FGB G-455A, ITGA2 C807T, ITGB3 T1565C and SERPINE1 5G-6754G associated with hemostasis disorders in a cohort of patients who sought medical care at the Almazov National Medical Research Center from 2018 to 2022.
Keywords
Supporting agencies: State assignment №123021000149-9
About the Authors
O. V. Sirotkina
Almazov National Medical Research Center» of the Ministry of Health of the Russian Federation; Petersburg Nuclear Physics Institute Named by B.P. Konstantinov of National Research Center «Kurchatov Institute»
Russian Federation
Russian Federation
2, Akkuratova st., St. Petersburg, 2197341; 1, mkr. Orlova roshcha, Gatchina, 188300
M. V. Kolegova
Almazov National Medical Research Center» of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
2, Akkuratova st., St. Petersburg, 2197341
E. Yu. Vasilyeva
Almazov National Medical Research Center» of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
2, Akkuratova st., St. Petersburg, 2197341
T. V. Vavilova
Almazov National Medical Research Center» of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
2, Akkuratova st., St. Petersburg, 2197341
References
1. Moran J., Bauer K.A. Managing thromboembolic risk in patients with hereditary and acquired thrombophilias. Blood. 2020; 135(5): 344-350.
2. Sirotkina O.V., Ulitina A.S., Maslennikov A.B., Vavilova T.V. Geneticheskiye faktory riska razvitiya trombozov: nakoplennyy opyt i novyye gorizonty. Molekulyarno-biologicheskiye tekhnologii v meditsinskoy praktike. Vyp. 31 [Genetic risk factors for thrombosis: accumulated experience and new horizons. Molecular biological technologies in medical practice. Issue 31]. Novosibirsk: Akademizdat, 2020:48-62. (In Russ.)
3. Nikitina D.I., Maretina M.A., Egorova A.A., et al. Ispol’zovaniye vysokorazreshayushchego analiza krivykh plavleniya DNK v diagnostike nasledstvennykh zabolevaniy [Application of highresolution DNA melting analysis in diagnostics of hereditary diseases]. Meditsinskaya genetika [Medical Genetics]. 2017;16(5):26- 33. (In Russ.)
4. Sirotkina O.V., Laskovets A.B., Pchelina S.N., et al. Molekulyarnogeneticheskiy analiz faktorov riska serdechno-sosudistykh zabolevaniy – staroye i novoye [Molecular genetic analysis of cardiovascular disease risk factors – old and new]. Meditsinskiy alfavit. Sovremennaya laboratoriya [Medical alphabet. Modern laboratory]. 2012;1:12-16. (In Russ.)
5. Sirotkina O.V., Ulitina A.S., Kolegova M.V., Tsykalenko E.A., Maslennikov A.B., Vavilova T.V. Riski trombozov: genotip i fenotip faktora V svertyvaniya krovi [Risks of thrombosis: genotype and phenotype of blood coagulation factor V]. Rossiyskiy zhurnal personalizirovannoy meditsiny [Russian Journal for Personalized Medicine]. 2022;2(1):35-42. (In Russ.)
6. Kachuri L., Chatterjee N., Hirbo J. et al. Principles and methods for transferring polygenic risk scores across global populations. Nat Rev Genet. 2024;25(1):8-25
7. Sirotkina O.V., Ulitina A.S., Kolegova M.V., et al. Mesto molekulyarno-geneticheskogo testirovaniya na nasledstvennuyu trombofiliyu v sovremennykh klinicheskikh rekomendatsiyakh i protokolakh. V sbornike: Diagnosticheskiye tsentry: ot profilaktiki do vysokikh tekhnologiy. Materialy XXXI yezhegodnoy konferentsii DiaMA s mezhdunarodnym uchastiyem [The place of molecular genetic testing for hereditary thrombophilia in modern clinical guidelines and protocols. In the collection: Diagnostic centers: from prevention to high technologies. Proceedings of the XXXI annual DiaMA conference with international participation]. 2023:172-173. (In Russ.)
8. Maslennikov A.B. Dostupnost’ klinicheskoy informatsii kak faktor dostovernosti molekulyarno-geneticheskoy diagnostiki [Availability of clinical information as a factor in the reliability of molecular genetic diagnostics]. Meditsinskaya genetika [Medical Genetics]. 2003;2(10):428. (In Russ.)
9. Maslennikov A.B. Organizatsionno-pravovyye aspekty genodiagnostiki nasledstvennykh zabolevaniy [Organizational and legal aspects of gene diagnostics of hereditary diseases]. Klinicheskaya laboratornaya diagnostika [Clinical laboratory diagnostics]. 2003;9:18. (In Russ.)
Review
For citations:
Sirotkina O.V., Kolegova M.V., Vasilyeva E.Yu., Vavilova T.V. Genetic variants associated with hemostatic disorders in patients seeking medical care in a multidisciplinary medical hospital. Medical Genetics. 2025;24(9):114-116. (In Russ.) https://doi.org/10.25557/2073-7998.2025.09.114-116
Views:
3
Email this article 